Nucleic acid binding, RNA binding
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S7WZA1
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 130 | 132 | PF00675 | 0.525 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.537 |
CLV_NRD_NRD_1 | 222 | 224 | PF00675 | 0.588 |
CLV_PCSK_KEX2_1 | 129 | 131 | PF00082 | 0.583 |
CLV_PCSK_KEX2_1 | 214 | 216 | PF00082 | 0.546 |
CLV_PCSK_KEX2_1 | 222 | 224 | PF00082 | 0.588 |
CLV_PCSK_PC1ET2_1 | 129 | 131 | PF00082 | 0.583 |
CLV_PCSK_PC1ET2_1 | 214 | 216 | PF00082 | 0.546 |
CLV_PCSK_PC7_1 | 126 | 132 | PF00082 | 0.481 |
CLV_PCSK_SKI1_1 | 126 | 130 | PF00082 | 0.533 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.488 |
DOC_CYCLIN_RxL_1 | 190 | 200 | PF00134 | 0.711 |
DOC_CYCLIN_yCln2_LP_2 | 120 | 123 | PF00134 | 0.609 |
DOC_MAPK_gen_1 | 173 | 180 | PF00069 | 0.545 |
DOC_PP2B_LxvP_1 | 120 | 123 | PF13499 | 0.609 |
DOC_PP2B_LxvP_1 | 195 | 198 | PF13499 | 0.718 |
DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.673 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.656 |
LIG_14-3-3_CanoR_1 | 37 | 44 | PF00244 | 0.461 |
LIG_Actin_WH2_2 | 113 | 128 | PF00022 | 0.629 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.630 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.516 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.555 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.454 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.748 |
LIG_HCF-1_HBM_1 | 134 | 137 | PF13415 | 0.513 |
LIG_IRF3_LxIS_1 | 18 | 24 | PF10401 | 0.505 |
LIG_LIR_Apic_2 | 51 | 57 | PF02991 | 0.538 |
LIG_LIR_Apic_2 | 69 | 73 | PF02991 | 0.562 |
LIG_LIR_Gen_1 | 134 | 144 | PF02991 | 0.526 |
LIG_LIR_Nem_3 | 134 | 140 | PF02991 | 0.531 |
LIG_LIR_Nem_3 | 24 | 29 | PF02991 | 0.436 |
LIG_PCNA_yPIPBox_3 | 114 | 126 | PF02747 | 0.591 |
LIG_SH2_CRK | 54 | 58 | PF00017 | 0.516 |
LIG_SH2_CRK | 70 | 74 | PF00017 | 0.300 |
LIG_SH2_GRB2like | 54 | 57 | PF00017 | 0.501 |
LIG_SH2_NCK_1 | 137 | 141 | PF00017 | 0.571 |
LIG_SH2_NCK_1 | 54 | 58 | PF00017 | 0.516 |
LIG_SH2_NCK_1 | 70 | 74 | PF00017 | 0.300 |
LIG_SH2_STAP1 | 137 | 141 | PF00017 | 0.525 |
LIG_SH2_STAP1 | 29 | 33 | PF00017 | 0.487 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.430 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.408 |
LIG_SH2_STAT5 | 29 | 32 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.426 |
LIG_SH3_3 | 158 | 164 | PF00018 | 0.525 |
LIG_SUMO_SIM_anti_2 | 19 | 24 | PF11976 | 0.484 |
LIG_SUMO_SIM_par_1 | 18 | 24 | PF11976 | 0.462 |
LIG_TRFH_1 | 70 | 74 | PF08558 | 0.588 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.523 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.561 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.657 |
MOD_GlcNHglycan | 219 | 222 | PF01048 | 0.652 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.670 |
MOD_GlcNHglycan | 228 | 231 | PF01048 | 0.689 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.418 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.677 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.704 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.636 |
MOD_GSK3_1 | 222 | 229 | PF00069 | 0.709 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.494 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.646 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.628 |
MOD_N-GLC_1 | 108 | 113 | PF02516 | 0.536 |
MOD_N-GLC_1 | 92 | 97 | PF02516 | 0.669 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.461 |
MOD_NEK2_1 | 216 | 221 | PF00069 | 0.644 |
MOD_PIKK_1 | 148 | 154 | PF00454 | 0.550 |
MOD_PKA_1 | 222 | 228 | PF00069 | 0.687 |
MOD_PKA_2 | 152 | 158 | PF00069 | 0.604 |
MOD_PKA_2 | 216 | 222 | PF00069 | 0.656 |
MOD_PKB_1 | 213 | 221 | PF00069 | 0.604 |
MOD_Plk_4 | 12 | 18 | PF00069 | 0.588 |
TRG_DiLeu_BaLyEn_6 | 1 | 6 | PF01217 | 0.621 |
TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.537 |
TRG_ENDOCYTIC_2 | 141 | 144 | PF00928 | 0.483 |
TRG_ER_diArg_1 | 130 | 132 | PF00400 | 0.482 |
TRG_ER_diArg_1 | 172 | 175 | PF00400 | 0.644 |
TRG_ER_diArg_1 | 212 | 215 | PF00400 | 0.543 |
TRG_NLS_MonoExtC_3 | 212 | 217 | PF00514 | 0.545 |
TRG_NLS_MonoExtN_4 | 211 | 218 | PF00514 | 0.603 |
TRG_Pf-PMV_PEXEL_1 | 37 | 41 | PF00026 | 0.488 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I303 | Leptomonas seymouri | 66% | 100% |
A0A1X0NZI8 | Trypanosomatidae | 45% | 91% |
A0A3R7P4N9 | Trypanosoma rangeli | 44% | 98% |
A4HE95 | Leishmania braziliensis | 85% | 100% |
A4I1P1 | Leishmania infantum | 100% | 100% |
C9ZK90 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9AXS5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 95% |
Q4Q9P6 | Leishmania major | 94% | 100% |